Affibody-Functionalized Elastin-like Peptide–Drug Conjugate Nanomicelle for Targeted Ovarian Cancer Therapy
Biomacromolecules · 2024
DOI: 10.1021/acs.biomac.4c00640 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomacromolecules, 2024. Verfasst von Qingrong Li und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Chemistry and Chemical Engineering, Shanghai Jiao Tong University, 800 Dongchuan Road, Shanghai 200240, People's Republic of China. Hauptthemen laut MEDLINE: Nanostructures, Ovarian Neoplasms, Erb-b2 Receptor Tyrosine Kinases. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 52 Literaturangaben. Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- School of Chemistry and Chemical Engineering, Shanghai Jiao Tong University, 800 Dongchuan Road, Shanghai 200240, People's Republic of China.
- State Key Laboratory of Microbial Metabolism, Joint International Research Laboratory of Metabolic & Developmental Sciences, and School of Life Sciences and Biotechnology, Shanghai Jiao Tong University, 800 Dongchuan Ro…
ORCID-Profile: Xiao-Xia Xia, Deyue Yan
Förderung
- National Key Research and Development Program of China
- National Natural Science Foundation of China
Zitieren
APA
Li, Q., Yang, X., Xia, X., Xia, X. X., & Yan, D. (2024). Affibody-Functionalized Elastin-like Peptide–Drug Conjugate Nanomicelle for Targeted Ovarian Cancer Therapy. Biomacromolecules. https://doi.org/10.1021/acs.biomac.4c00640
Vancouver
Li Q, Yang X, Xia X, Xia XX, Yan D. Affibody-Functionalized Elastin-like Peptide–Drug Conjugate Nanomicelle for Targeted Ovarian Cancer Therapy. Biomacromolecules. 2024. doi:10.1021/acs.biomac.4c00640
BibTeX
@article{Li2024,
author = {Li, Qingrong and Yang, Xiaoyuan and Xia, Xuelin and Xia, Xiao-Xia and Yan, Deyue},
title = {Affibody-Functionalized Elastin-like Peptide–Drug Conjugate Nanomicelle for Targeted Ovarian Cancer Therapy},
journal = {Biomacromolecules},
year = {2024},
doi = {10.1021/acs.biomac.4c00640}
}
EUVIMED